Education
About Us
Working with TipRanks
Follow Us
Mabion SA (DE:272)
FRANKFURT:272
Mabioncd20 (Candidate Biosimilar To Rituximab), Mabthera®, Rituxan®
Rheumatoid Arthritis
Phase III
Withdrawn
MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis
Dec 02, 2020
―
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
Diffuse Large B-Cell Lymphoma
Phase III
Completed
MabionCD20 Compared to MabThera in Lymphoma Patients
Nov 12, 2015
―
Rituximab
Rheumatoid Arthritis
Phase III
Completed
MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis
Jun 09, 2015
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mabion SA (272) have in its pipeline
272 is currently developing the following drugs: Mabioncd20 (Candidate Biosimilar To Rituximab), Mabthera®, Rituxan®, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.